Cookies

Like most websites The Pathologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Biochemistry and molecular biology

Subspecialties Oncology

Kill Command for Cancer

| Luke Turner

Naturally occurring miRNA sequences can be deadly to cancer cells, but can this be ramped up to maximize toxicity?

Subspecialties Oncology

Quick Hits

| Luke Turner

Discover the latest in pathology and laboratory medicine with this roundup of short news stories

Subspecialties Biochemistry and molecular biology

Identifying Parkinson’s Inhibitors

| Luke Turner

An innovative approach aims to find the most effective inhibitors of α-synuclein protein aggregation, which is a leading cause of Parkinson’s disease

Subspecialties Biochemistry and molecular biology

Journey to the Center of the Cell

| Luke Turner

A 3D model allows scientists to view live human cells in an unprecedented way, using an algorithm to display the shape and location of its structures

Subspecialties Analytical science

A Lasting Legacy

| Mary J. Wirth

A story of war, famine, epigenetics, and how all three colluded to change the phenotype of a generation of babies – and beyond

Diagnostics Analytical science

Sensing the Tiniest Change

| Menno Prins

New biomarker sensing technology can detect miniscule concentrations of molecules in the blood to assist with patient monitoring

Outside the Lab Genetics and epigenetics

A Global Citizen

We sit down with Malak Abedalthagafi to talk about the biggest issues facing pathology and how she has adapted to working around the globe

Inside the Lab Clinical care

Biochip Breakthrough

| Luke Turner

With antimicrobial resistance an ever-increasing threat to modern medicine, a new breakthrough may rapidly identify drug-resistant microbe strains to ensure effective treatment

Inside the Lab Biochemistry and molecular biology

One Drop at a Time

| Alexander Dobrovic and Cloud Paweletz

When seeking the greatest benefit from liquid biopsy, droplet digital PCR can help by offering speed, sensitivity, and absolute quantitation

Outside the Lab Biochemistry and molecular biology

Pre-Empting Relapse

| Luke Turner

A new DNA test that can detect treatment-resistant mutations could prove crucial for patients with acute myeloid leukemia, providing an early indication that targeted therapeutic intervention is needed

Newsletter

Send me the latest from The Pathologist.

Sign up now

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register